Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event
2020 · JAMA Cardiology · 84 citations
https://doi.org/10.1001/jamacardio.2020.6455
K
Karin Brandner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
100
Citations
2
h-index
2
i10-index
Karin Brandner is an academic researcher. The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiovascular Function and Risk Factors & Venous Thromboembolism Diagnosis and Management. The author has an h-index of 2, co-authored 3 publications.
Papers by this author
worksVericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
2025 · The Lancet · 49 citations
https://doi.org/10.1016/s0140-6736(25)01682-4
Thermic sealing in femoral catheterization: First experience with the Secure Device
2018 · Cardiology Journal · 0 citations
https://doi.org/10.5603/cj.a2018.0035
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat